MAPT and Alzheimer disease: If we combine tau measurements in TBS and SI in each group, including phosphorylated and non-phosphorylated tau species, it becomes even more evident that total tau content appears to be substantially more abundant in AD brain than in controls, CBD, PSP, and PiD.